Nader Francois has filed 5 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 20400 shares of Tectonic Therapeutic, Inc. ($TECX) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Tectonic Therapeutic, Inc. | $TECX | Nader Francois | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 18,716,280 | 9999.99% | 0.11% |
| April 30, 2025 | Moderna, Inc. | $MRNA | Nader Francois | Director | A | Stock Option (Right to Buy) | 6378 | $0.00 | 6,378.0000 | 384,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | Nader Francois | Director | A | Restricted Stock Units | 12174 | $0.00 | 12,174.0000 | 384,000,000 | 9999.99% | 0.00% |
| May 6, 2024 | Moderna, Inc. | $MRNA | Nader Francois | Director | A | Stock Option (Right to Buy) | 7557 | $0.00 | 7,557.0000 | 382,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Moderna, Inc. | $MRNA | Nader Francois | Director | A | Stock Option (Right to Buy) | 6134 | $0.00 | 6,134.0000 | 416,000,000 | 9999.99% | 0.00% |